An antibody specific for full-length ERβ, hereafter referred to as ERβ1, has been used previously to delineate the pattern of expression of this isoform of the receptor in breast cancer biopsies (Saunders et al, 2002b; Carder et al, 2005). Here, ESR2 is linked to breast carcinoma.